Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. May 14, 2015; 21(18): 5505-5512
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5505
Figure 1
Figure 1 Cumulative local recurrence between the LRR and ORR groups. A: 5-year: 16.0% vs 16.4%, P = 0.753; B: 5-year: stage II 6.3% vs 8.7%, P = 0.623; stage III 26.4% vs 23.2%, P = 0.747.
Figure 2
Figure 2 Cumulative disease-free survival between the LRR and ORR groups. A: 5-year: 63.0% vs 63.1%, P = 0.589; B: 5-year: stage II 77.5% vs 77.6%, P = 0.462; stage III 46.5% vs 50.9%, P = 0.738.
Figure 3
Figure 3 Cumulative overall survival between the LRR and ORR groups. A: 5-year: 68.1% vs 63.5%, P = 0.682; B: 5-year: stage II 81.4% vs 74.3%, P = 0.242; stage III 53.9% vs 54.1%, P = 0.459.